1-7 of 7
Christel Van Geet, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

99.3% of Inhibitors in Severe Hemophilia a Develop before Exposure Day 75. Time to Change Definition of Previously Treated Patients; Data from 1038 Patients with Severe Hemophilia a of the Pednet Registry

Marijke Van den Berg, MD PhD, Kathelijn Fischer, Elena Santagostino, Herve Chambost, Karin Kurnik, Gili Kenet, MD, Christoph Male, MD, Anne Rafowicz, Helen Platokouki, Susanna Ranta, MD PhD, Christel Van Geet, MD, Johannes Oldenburg, Ri Liesner, Segolene Claeyssens, MD, Nadine Gretenkort-Andersson, Anne Mäkipernaa, PhD, Torben Stamm Mikkelsen, Manuel Carcao, Beatrice Nolan, Liz Chalmers, A.R. Cid, Teresa Álvarez-Roman, Carmen Altisent, Georges Rivard, MD FRCPC, Claudio Molinari, Martina Buehrlen, Rainer Kobelt, Carmen Escuriola, Manuela Carvalho, Christoph Koenigs, MD PhD, Mike Williams, Rolf Ljung, MD PhD Professor
Journal: Blood
Blood (2018) 132 (Supplement 1): 2472.
https://doi.org/10.1182/blood-2018-99-114518
Published: 2018
Journal Articles

Risk Factors for the Development of High-Titer Inhibitors in 260 Children with Severe Hemophilia a Born Between 1990 and 2009: The Remain Study

Maria Elisa Mancuso, MD PhD, Kathelijn Fischer, MD PhD MSc, Elena Santagostino, MD PhD, Johannes Oldenburg, Prof, Helen Platokouki, MD, Christoph Königs, MD PhD, Carmen Escuriola, MD, Georges-Etienne Rivard, MD, Ana Cid, MD, Manuel Carcao, MD, Rolf Ljung, MD PhD, Pia Petrini, MD, Anne Rafowicz, MD, Carmen Altisent, MD, Gili Kenet, MD, Raina Liesner, Karin Kurnik, MD, Christel Van Geet, MD PhD, Teresa Alvarez-Roman, MD, Tin Tin Yee, MD, Guenter Auerswald, Sr., MD, Rosario Perez-Garrido, MD, Beatrice Nolan, Hervé Chambost, Anne Makipernaa, MD, Angelo Claudio Molinari, MD, Angela Thomas, MBBS, PhD, Elizabeth Chalmers, MD, Mike Williams, MD, Rainer Kobelt, MD, Marijke Van den Berg, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3774.
https://doi.org/10.1182/blood.V128.22.3774.3774
Published: 2016
Journal Articles

First Report of Transheterozygosity in a Patient with An Inherited Platelet Bleeding Disorder Due to Mutations in the Thromboxane A2 Receptor ( TBXA2R) and cyclooxygenase1 ( PTGS1) ,

Kathleen Freson, Chantal Thys, Christel Van Geet, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3260.
https://doi.org/10.1182/blood.V118.21.3260.3260
Published: 2011
Journal Articles

Proteomic Analysis Reveals That the Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Inhibits Megakaryopoiesis by Preventing Apoptosis

Michela Di Michele, Karen Peeters, Serena Loyen, Etienne Waelkens, Lutberg Overbergh, Marc Hoylearts, Christel Van Geet, MD, PhD, Kathleen Freson
Journal: Blood
Blood (2010) 116 (21): 4791.
https://doi.org/10.1182/blood.V116.21.4791.4791
Published: 2010
Journal Articles

Loss of Gs Activity in Platelets from Carriers with a Heterozygous Missense Mutation in the Regulator of G Protein Signaling 2 (RGS2)

Laura Noé, Kathleen Freson, Elke Giets, Chantal Thijs, Christine Wittevrongel, Christel Van Geet, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2861.
https://doi.org/10.1182/blood.V112.11.2861.2861
Published: 2008
Journal Articles

GPVI Mutation and Absent Platelet Collagen Activation in a Patient with a Bleeding Disorder.

Kathleen Freson, PhD, Cedric Hermans, MD, PhD, Chantal Thys, Christel Van Geet, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2106.
https://doi.org/10.1182/blood.V110.11.2106.2106
Published: 2007
Journal Articles

Development of Megakaryocyte-Specific Lentiviral Vectors for Gene Therapy of Platelet Disorders.

Liesbeth De Waele, MD, Kathleen Freson, PhD, Chantal Thys, Christel Van Geet, MD, PhD, Désiré Collen, MD, PhD, Thierry VandenDriessche, PhD, Marinee Chuah, PhD
Journal: Blood
Blood (2007) 110 (11): 5143.
https://doi.org/10.1182/blood.V110.11.5143.5143
Published: 2007